Mesenchymal stem cell insights: Prospects in cardiovascular therapy

Cell Transplantation

Volumn 23, Issue 4-5, 2014, Pages 513-529

  Chou, Shiu Huey ^a   Lin, Shinn Zong ^b   Kuo, Wei Wen ^b   Pai, Peiying ^c   Lin, Jing Ying ^d   Lai, Chao Hung ^e   Kuo, Chia Hua ^f   Lin, Kuan Ho ^b,c   Tsai, Fuu Jen ^b   Huang, Chih Yang ^b,g  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b CHINA MEDICAL UNIVERSITY   (Taiwan)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^d CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^e TAICHUNG ARMED FORCES GENERAL HOSPITAL   (Taiwan)

^f UNIVERSITY OF TAIPEI   (Taiwan)

^g ASIA UNIVERSITY   (Taiwan)

Author keywords

Cellular therapy; Differentiation; Mesenchymal stem cells (MSCs); Myocardial infarction; Niche; Paracrine; Regeneration

Indexed keywords

CARDIOVASCULAR DISEASE; CELL REGENERATION; CELL TRANSDIFFERENTIATION; HEART MUSCLE CELL; HUMAN; MESENCHYMAL STEM CELL TRANSPLANTATION; NONHUMAN; PARACRINE SIGNALING; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; STEM CELL NICHE; TISSUE REGENERATION; ANIMAL; CELL DIFFERENTIATION; CYTOLOGY; HEART; MESENCHYMAL STROMA CELL; METABOLISM; MYOCARDIAL INFARCTION; PHYSIOLOGY; REGENERATION;

ANIMALS; CELL DIFFERENTIATION; HEART; HUMANS; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MYOCARDIAL INFARCTION; PARACRINE COMMUNICATION; REGENERATION; STEM CELL NICHE;

EID: 84900389324     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/096368914X678436     Document Type: Review

References (134)

1. Alvarez-Dolado, M.; Pardal, R.; Garcia-Verdugo, J. M.; Fike, J. R.; Lee, H. O.; Pfeffer, K.; Lois, C.; Morrison, S. J.; Alvarez-Buylla, A. Fusion of bone-marrow-derived cells with Purkinje neurons, cardiomyocytes and hepatocytes. Nature 425:968-973; 2003.
2. Amado, L. C.; Saliaris, A. P.; Schuleri, K. H.; St John, M.; Xie, J. S.; Cattaneo, S.; Durand, D. J.; Fitton, T.; Kuang, J. Q.; Stewart, G.; Lehrke, S.; Baumgartner, W. W.; Martin, B. J.; Heldman, A. W.; Hare, J. M. Cardiac repair with intramyocardial injection of allogeneic mesenchymal stem cells after myocardial infarction. Proc. Natl. Acad. Sci. USA 102:11474-11479; 2005.
3. Amsalem, Y.; Mardor, Y.; Feinberg, M. S.; Landa, N.; Miller, L.; Daniels, D.; Ocherashvilli, A.; Holbova, R.; Yosef, O.; Barbash, I. M.; Leor, J. Iron-oxide labeling and outcome of transplanted mesenchymal stem cells in the infarcted myocardium. Circulation 116:I38-I45; 2007.
4. Assmus, B.; Schächinger, V.; Teupe, C.; Britten, M.; Lehmann, R.; Döbert, N.; Grünwald, F.; Aicher, A.; Urbich, C.; Martin, H.; Hoelzer, D.; Dimmeler, S.; Zeither, A. M. Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCAREAMI). Circulation 106:3009-3017; 2002.
5. Balana, B.; Nicoletti, C.; Zahanich, I.; Graf, E. M.; Christ, T.; Boxberger, S.; Ravens, U. 5-Azacytidine induces changes in electrophysiological properties of human mesenchymal stem cells. Cell Res. 16:949-960; 2006.
6. Bartholomew, A.; Sturgeon, C.; Siatskas, M.; Ferrer, K.; McIntosh, K.; Patil, S.; Hardy, W.; Devine, S.; Ucker, D.; Deans, R.; Moseley, A.; Hoffman, R. Mesenchymal stem cells suppress lymphocyte proliferation in vitro and prolong skin graft survival in vivo. Exp. Hematol. 30:42-48; 2002.
7. Bartunek, J.; Croissant, J. D.; Wijns, W.; Gofflot, S.; de Lavareille, A.; Vanderheyden, M.; Kaluzhny, Y.; Mazouz, N.; Willemsen, P.; Penicka, M.; Mathieu, M.; Homsy, C.; De Bruyne, B.; McEntee, K.; Lee, I. W.; Heyndrickx, G. R. Pretreatment of adult bone marrow mesenchymal stem cells with cardiomyogenic growth factors and repair of the chronically infarcted myocardium. Am. J. Physiol. Heart Circ. Physiol. 292:H1095-1104; 2007.
8. Bartunek, J.; Wijns, W.; Dolatabadi, D.; Vanderheyden, M.; Dens, J.; Ostojic, M.; Behfar, A.; Henry, S.; Tendera, M.; Waldman, S. C-cure multicenter trial: Lineage specified bone marrow derived cardiopoietic mesenchymal stem cells for treatment of ischemic cardiomyopathy. J. Am. Coll. Cardiol. 57:200; 2011.
9. Behfar, A.; Zingman, L. V.; Hodgson, D. M.; Rauzier, J. M.; Kane, G. C.; Terzic, A.; Pucéat, M. Stem cell differentiation requires a paracrine pathway in the heart. FASEB J. 16:1558-1566; 2002.
10. Beltrami, A. P.; Barlucchi, L.; Torella, D.; Baker, M.; Limana, F.; Chimenti, S.; Kasahara, H.; Rota, M.; Musso, E.; Urbanek, K.; Leri, A.; Kajstura, J.; Nadal-Ginard, B.; Anversa, P. Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114:763-776; 2003.
11. Beltrami, A. P.; Urbanek, K.; Kajstura, J.; Yan, S. M.; Finato, N.; Bussani, R.; Nadal-Ginard, B.; Silvestri, F.; Leri, A.; Alberto Beltrami, C.; Anversa, P. Evidence that human cardiac myocytes divided after myocardial infarction. N. Engl. J. Med. 344:1750-1757; 2011.
12. Bernardo, M. E.; Locatelli, F.; Fibbe, W. E. Mesenchymal stromal cells: A novel treatment modality for tissue repair. Ann. NY Acad. Sci. 1176:101-117; 2009.
13. Bernhardt, W. M.; Warnecke, C.; Willam, C.; Tanaka, T.; Wiesener, M. S.; Eckardt, K. U. Organ protection by hypoxia and hypoxia inducible factors. Methods Enzymol. 435: 221-245; 2007.
14. Beyth, S.; Borovsky, Z.; Mevorach, D.; Liebergall, M.; Gazit, Z.; Aslan, H.; Galun, E.; Rachmilewitz, J. Human mesenchymal stem cells alter antigen-presenting cell maturation and induce T-cell unresponsiveness. Blood 105:2214-2219; 2005.
15. Bittira, B.; Shum-Tim, D.; Al-Khaldi, A.; Chiu, R. C. J. Mobilization and homing of bone marrow stromal cells in myocardial infarction. Eur. J. Cardio-Thorac. Surg. 24: 393-398; 2003.
16. Breitbach, M.; Bostani, T.; Roell, W.; Xia, Y.; Dewald, O.; Nygren, J. M.; Fries, J. W.; Tiemann, K.; Bohlen, H.; Hescheler, J.; Welz, A.; Bloch, W.; Jacobsen, S. E.; Fleischmann, B. K. Potential risks of bone marrow cell transplantation into infarcted hearts. Blood 110:1362-1369; 2007.
17. Caplan, A. I.; Dennis, J. E. Mesenchymal stem cells as trophic mediators. J. Cell. Biochem. 98:1076-1084; 2006.
18. Caspi, O.; Huber, I.; Kehat, I.; Habib, M.; Arbel, G.; Gepstein, A.; Yankelson, L.; Aronson, D.; Beyar, R.; Gepstein, L. Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts. J. Am. Coll. Cardiol. 50:1884-1893; 2007.
19. Chen, S. L.; Fang, W. W.; Ye, F.; Liu, Y. H.; Qian, J.; Shan, S. J.; Zhang, J. J.; Chunhua, R. Z.; Liao, L. M.; Lin, S.; Sun, J. P. Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction. J. Am. Coll. Cardiol. 94:92-95; 2004.
20. Chou, S. H.; Lin, S. Z.; Day, C. H.; Kuo, W. W.; Shen, C. Y.; Hsieh, D. J.; Lin, J. Y.; Tsai, F. J.; Tsai, C. H.; Huang, C. Y. Mesenchymal stem cell insights: Prospects in hematological transplantation. Cell Transplant. 22: 711-721; 2013.
21. - stroma cells with immunosuppressant activity against ischemia/reperfusion injury in rats. Chinese J. Physiol. 54:169-182; 2011.
22. Chung, Y. S.; Huang, C. Y.; Ma, M. C.; Chu, C. C.; Chiang, H. S.; Lin, L. J.; Chou, S. H. Cardiac injury protection from mouse bone marrow stromal cells with in utero transplantation followed by secondary postnatal boost. Chin. J. Physiol. 54:205-218; 2011.
23. Corcione, A.; Benvenuto, F.; Ferretti, E.; Giunti, D.; Cappiello, V.; Cazzanti, F.; Risso, M.; Gualandi, F.; Mancardi, G.; Pistoia, V.; Uccelli, A. Human mesenchymal stem cells modulate B-cell functions. Blood 107:367-372; 2006.
24. Dawn, B.; Stein, A. B.; Urbanek, K.; Rota, M.; Whang, B.; Rastaldo, R.; Torella, D.; Tang, X. L.; Rezazadeh, A.; Kajstura, J.; Leri, A.; Hunt, G.; Varma, J.; Prabhu, S. D.; Anversa, P.; Bolli, R. Cardiac stem cells delivered intravascularly traverse the vessel barrier, regenerate infarcted myocardium, and improve cardiac function. Proc. Natl. Acad. Sci. USA 102:3766-3771; 2005.
25. Deans, R. J.; Moseley, A. B. Mesenchymal stem cells: Biology and potential clinical uses. Exp. Hematol. 28:875-884; 2000.
26. Di Nicola, M.; Carlo-Stella, C.; Magni, M.; Milanesi, M.; Longoni, P. D.; Matteucci, P.; Grisanti, S.; Gianni, A. M. Human bone marrow stromal cells suppress T-lymphocyte proliferation induced by cellular or nonspecific mitogenic stimuli. Blood 99:3838-3843; 2002.
27. Doetschman, T. C.; Eistetter, H.; Katz, M.; Schmidt, W.; Kemler, R. The in vitro development of blastocystderived embryonic stem cell lines: Formation of visceral yolk sac, blood islands and myocardium. J. Embryol. Exp. Morphol. 87:27-45; 1985.
28. Elnakish, M. T.; Hassan, F.; Dakhlallah, D.; Marsh, C. B.; Alhaider, I. A.; Khan, M. Mesenchymal stem cells for cardiac regeneration: Translation to bedside reality. Stem Cells Int. 2012:646038; 2012.
29. Erices, A.; Conget, P.; Minguell, J. J. Mesenchymal progenitor cells in human umbilical cord blood. Br. J. Haematol. 109:235-242; 2000.
30. Fedak, P. W.; Verma, S.; Weisel, R. D.; Li, R. K. Cardiac remodeling and failure: From molecules to man (Part I). Cardiovasc. Pathol. 14:1-11; 2005.
31. Fernández-Avilés, F.; San Román, J. A.; García-Frade, J.; Fernández, M. E.; Peñarrubia, M. J.; de la Fuente, L.; Gómez-Bueno, M.; Cantalapiedra, A.; Fernández, J.; Gutierrez, O.; Sánchez, P. L.; Hernández, C.; Sanz, R.; García-Sancho, J.; Sánchez, A. Experimental and clinical regenerative capability of human bone marrow cells after myocardial infarction. Circ. Res. 95:742-748; 2004.
32. Feygin, J.; Mansoor, A.; Eckman, P.; Swingen, C.; Zhang, J. Functional and bioenergetic modulations in the infarct border zone following autologous mesenchymal stem cell transplantation. Am. J. Physiol. Heart Circ. Physiol. 293: H1772-H1780; 2007.
33. Fijnvandraat, A. C.; van Ginneken, A. C. G.; Schumacher, C. A.; Boheler, K. R.; Lekanne Deprez, R. H.; Christoffels, V. M.; Moorman, A. F. M. Cardiomyocytes purified from differentiated embryonic stem cells exhibit characteristics of early chamber myocardium. J. Mol. Cell. Cardiol. 35: 1461-1472; 2003.
34. Finegold, J. A.; Asaria, P.; Francis, D. P. Mortality from ischaemic heart disease by country, region, and age: Statistics from World Health Organisation and United Nations. Int. J. Cardiol.168:934-945; 2013.
35. Friedenstein, A. J.; Chailakhjan, R. K.; Lalykina, K. S. The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Tissue Kinet. 3:393-403; 1970.
36. Friedenstein, A. J.; Chailakhyan, R. K.; Latsinik, N. V.; Panasyuk, A. F.; Keiliss-Borok, I. V. Stromal cells responsible for transferring the microenvironment of the hemopoietic tissues. Cloning in vitro and retransplantation in vivo. Transplantation 17:331-340; 1974.
37. Friedenstein, A. J.; Petrakova, K. V.; Kurolesova, A. I.; Frolova, G. P. Heterotopic transplants of bone marrow. Transplantation 6:230-247; 1968.
38. Ghostine, S.; Carrion, C.; Souza, L. C.; Richard, P.; Bruneval, P.; Vilquin, J. T.; Pouzet, B.; Schwartz, K.; Menasché, P.; Hagège, A. A. Long-term efficacy of myoblast transplantation on regional structure and function after myocardial infarction. Circulation 106:I131-I136; 2002.
39. Gnecchi, M.; Zhang, Z.; Ni, A.; Dzau, V. J. Paracrine mechanisms in adult stem cell signaling and therapy. Circ. Res. 103:1204-1019; 2008.
40. Hamamoto, H.; Gorman, J. H.; Ryan, L. P.; Hinmon, R.; Martens, T. P.; Schuster, M. D.; Plappert, T.; Kiupel, M.; St John-Sutton, M. G.; Itescu, S.; Gorman, R. C. Allogeneic mesenchymal precursor cell therapy to limit remodeling after myocardial infarction: The effect of cell dosage. Ann. Thorac. Surg. 87:794-801; 2009.
41. Hare, J. M.; Traverse, J. H.; Henry, T. D.; Dib, N.; Strumpf, R. K.; Schulman, S. P.; Gerstenblith, G.; DeMaria, A. N.; Denktas, A. E.; Gammon, R. S.; Hermiller, Jr., J. B.; Reisman, M. A.; Schaer, G. L.; Sherman, W. A randomized, double-blind, placebo-controlled, dose-escalation study of intravenous adult human mesenchymal stem cells (prochymal) after acute myocardial infarction. J. Am. Coll. Cardiol. 54:2277-2286; 2009.
42. Hierlihy, A. M.; Seale, P.; Lobe, C. G.; Rudnicki, M. A.; Megeney, L. A. The post-natal heart contains a myocardial stem cell population. FEBS Lett. 530:239-243; 2002.
43. Higuchi, H.; Hara, M.; Yamamoto, K.; Miyamoto, T.; Kinoshita, M.; Yamada, T.; Uchiyama, K.; Matsumori, A. Mast cells play a critical role in the pathogenesis of viral myocarditis. Circulation 118:363-372; 2008.
44. Hutcheson, K. A.; Atkins, B. Z.; Hueman, M. T.; Hopkins, M. B.; Glower, D. D.; Taylor, D. A. Comparison of benefits on myocardial performance of cellular cardiomyoplasty with skeletal myoblasts and fibroblasts. Cell Transplant. 9:359-368; 2000.
45. Jackson, K. A.; Majka, S. M.; Wang, H.; Pocius, J.; Hartley, C. J.; Majesky, M. W.; Entman, M. L.; Michael, L. H.; Hirschi, K. K.; Goodell, M. A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-1402; 2001.
46. Jain, M.; DerSimonian, H.; Brenner, D. A.; Ngoy, S.; Teller, P.; Edge, A. S.; Zawadzka, A.; Wetzel, K.; Sawyer, D. B.; Colucci, W. S.; Apstein, C. S.; Liao, R. Cell therapy attenuates deleterious ventricular remodeling and improves cardiac performance after myocardial infarction. Circulation 103:1920-1927; 2001.
47. Janssens, S.; Dubois, C.; Bogaert, J.; Theunissen, K.; Deroose, C.; Desmet, W.; Kalantzi, M.; Herbots, L.; Sinnaeve, P.; Dens, J.; Maertens, J.; Rademakers, F.; Dymarkowski, S.; Gheysens, O.; Van Cleemput, J.; Bormans, G.; Nuyts, J.; Belmans, A.; Mortelmans, L.; Boogaerts, M.; Van de Werf, F. Autologous bone marrowderived stem-cell transfer in patients with ST-segment elevation myocardial infarction: Double-blind, randomised controlled trial. Lancet 367:113-121; 2006.
48. Jujo, K.; Ii, M.; Losordo, D. W. Endothelial progenitor cells in neovascularization of infarcted myocardium. J. Mol. Cell. Cardiol. 45:530-544; 2008.
49. Kadivar, M.; Khatami, S.; Mortazavi, Y.; Shokrgozar, M. A.; Taghikhani, M.; Soleimani, M. In vitro cardiomyogenic potential of human umbilical vein-derived mesenchymal stem cells. Biochem. Biophys. Res. Commun. 340:639-647; 2006.
50. Kajstura, J.; Leri, A.; Finato, N.; Di Loreto, C.; Beltrami, C. A.; Anversa, P. Myocyte proliferation in end-stage cardiac failure in humans. Proc. Natl. Acad. Sci. USA 95: 8801-8805; 1998.
51. Kalinina, N. I.; Sysoeva, V. Y.; Rubina, K. A.; Parfenova, Y. V.; Tkachuk, V. A. Mesenchymal stem cells in tissue growth and repair. Acta Naturae 3:30-37; 2011.
52. Kamihata, H.; Matsubara, H.; Nishiue, T.; Fujiyama, S.; Tsutsumi, Y.; Ozono, R.; Masaki, H.; Mori, Y.; Iba, O.; Tateishi, E.; Kosaki, A.; Shintani, S.; Murohara, T.; Imaizumi, T.; Iwasaka, T. Implantation of bone marrow mononuclear cells into ischemic myocardium enhances collateral perfusion and regional function via side supply of angioblasts, angiogenic ligands, and cytokines. Circulation 104:1046-1052; 2001.
53. + bone marrow-derived heart-resident cells suppress experimental autoimmune myocarditis. Cardiovasc. Res. 80:236-245; 2008.
54. Katritsis, D. G.; Sotiropoulou, P. A.; Karvouni, E.; Karabinos, I.; Korovesis, S.; Perez, S. A.; Voridis, E. M.; Papamichail, M. Transcoronary transplantation of autologous mesenchymal stem cells and endothelial progenitors into infarcted human myocardium. Catheter. Cardiovasc. Interv. 65:321-329; 2005.
55. Kawamoto, A.; Tkebuchava, T.; Yamaguchi, J.; Nishimura, H.; Yoon, Y. S.; Milliken, C.; Uchida, S.; Masuo, O.; Iwaguro, H.; Ma, H.; Hanley, A.; Silver, M.; Kearney, M.; Losordo, D. W.; Isner, J. M.; Asahara, T. Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461-468; 2003.
56. Kehat, I.; Kenyagin-Karsenti, D.; Snir, M.; Segev, H.; Amit, M.; Gepstein, A.; Livne, E.; Binah, O.; Itskovitz-Eldor, J.; Gepstein, L. Human embryonic stem cells can differentiate into myocytes with structural and functional properties of cardiomyocytes. J. Clin. Invest. 108:407-414; 2001.
57. Kinnaird, T.; Stabile, E.; Burnett, M. S.; Lee, C. W.; Barr, S.; Fuchs, S.; Epstein, S. E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94:678-685; 2004.
58. Klug, M. G.; Soonpaa, M. H.; Koh, G. Y.; Field, L. J. Genetically selected cardiomyocytes from differentiating embryonic stem cells form stable intracardiac grafts. J. Clin. Invest. 98:216-224; 1996.
59. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436; 2001.
60. Kolossov, E.; Bostani, T.; Roell, W.; Breitbach, M.; Pillekamp, F.; Nygren, J. M.; Sasse, P.; Rubenchik, O.; Fries, J. W.; Wenzel, D.; Geisen, C.; Xia, Y.; Lu, Z.; Duan, Y.; Kettenhofen, R.; Jovinge, S.; Bloch, W.; Bohlen, H.; Welz, A.; Hescheler, J.; Jacobsen, S. E.; Fleischmann, B. K. Engraftment of engineered ES cell-derived cardiomyocytes but not BM cells restores contractile function to the infarcted myocardium. J. Exp. Med. 203:2315-2327; 2006.
61. Kortesidis, A.; Zannettino, A.; Isenmann, S.; Shi, S.; Lapidot, T.; Gronthos, S. Stromal-derived factor-1 promotes the growth, survival, and development of human bone marrow stromal stem cells. Blood 105:3793-3801; 2005.
62. Laflamme, M. A.; Chen, K. Y.; Naumova, A. V.; Muskheli, V.; Fugate, J. A.; Dupras, S. K.; Reinecke, H.; Xu, C.; Hassanipour, M.; Police, S.; O'Sullivan, C.; Collins, L.; Chen, Y.; Minami, E.; Gill, E. A.; Ueno, S.; Yuan, C.; Gold, J.; Murry, C. E. Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts. Nat. Biotechnol. 25:1015-1024; 2007.
63. + cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433:647-653; 2005.
64. Le Blanc, K.; Tammik, L.; Sundberg, B.; Haynesworth, S. E.; Ringdén, O. Mesenchymal stem cells inhibit and stimulate mixed lymphocyte cultures and mitogenic responses independently of the major histocompatibility complex. Scand. J. Immunol. 57:11-20; 2003.
65. Lunde, K.; Solheim, S.; Aakhus, S.; Arnesen, H.; Abdelnoor, M.; Egeland, T.; Endresen, K.; Ilebekk, A.; Mangschau, A.; Fjeld, J. G.; Smith, H. J.; Taraldsrud, E.; Grøgaard, H. K.; Bjørnerheim, R.; Brekke, M.; Müller, C.; Hopp, E.; Ragnarsson, A.; Brinchmann, J. E.; Forfang, K. Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction. N. Engl. J. Med. 355:1199-1209; 2006.
66. Lushaj, E. B.; Anstadt, E.; Haworth, R.; Roenneburg, D.; Kim, J.; Hematti, P.; Kohmoto, T. Mesenchymal stromal cells are present in the heart and promote growth of adult stem cells in vitro. Cytotherapy 13:400-406; 2011.
67. Majumdar, M. K.; Keane-Moore, M.; Buyaner, D.; Hardy, W. B.; Moorman, M. A.; Mclntosh, K. R.; Mosca, J. D. Characterization and functionality of cell surface molecules on human mesenchymal stem cells. J. Biomed. Sci. 10:228-241; 2003.
68. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S.; Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697-705; 1999.
69. Manabe, I.; Shindo, T.; Nagai, R. Gene expression in fibroblasts and fibrosis: Involvement in cardiac hypertrophy. Circ. Res. 91:1103-1113; 2002.
70. Martens, T. P.; See, F.; Schuster, M. D.; Sondermeijer, H. P.; Hefti, M. M.; Zannettino, A.; Gronthos, S.; Seki, T.; Itescu, S. Mesenchymal lineage precursor cells induce vascular network formation in ischemic myocardium. Nat. Clin. Pract. Cardiovasc. Med. 3:S18-S22; 2006.
71. Mazhari, R.; Hare, J. M. Mechanisms of action of mesenchymal stem cells in cardiac repair: Potential influences on the cardiac stem cell niche. Nat. Clin. Pract. Cardiovasc. Med. 4:S21-S26; 2007.
72. Ménard, C.; Hagège, A. A.; Agbulut, O.; Barro, M.; Morichetti, M. C.; Brasselet, C.; Bel, A.; Messas, E.; Bissery, A.; Bruneval, P.; Desnos, M.; Pucéat, M.; Menasché, P. Transplantation of cardiac-committed mouse embryonic stem cells to infarcted sheep myocardium: A preclinical study. Lancet 366:1005-1012; 2005.
73. Menasché, P.; Hagège, A. A.; Scorsin, M.; Pouzet, B.; Desnos, M.; Duboc, D.; Schwartz, K.; Vilquin, J. T.; Marolleau, J. P. Myoblast transplantation for heart failure. Lancet 357:279-280; 2001.
74. Menasché, P.; Hagège, A. A.; Vilquin, J. T.; Desnos, M.; Abergel, E.; Pouzet, B.; Bel, A.; Sarateanu, S.; Scorsin, M.; Schwartz, K.; Bruneval, P.; Benbunan, M.; Marolleau, J. P.; Duboc, D. Autologous skeletal myoblast transplantation for severe postinfarction left ventricular dysfunction. J. Am. Coll. Cardiol. 41:1078-1083; 2003.
75. Meyer, G. P.; Wollert, K. C.; Lotz, J.; Steffens, J.; Lippolt, P.; Fichtner, S.; Hecker, H.; Schaefer, A.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary bone marrow cell transfer after myocardial infarction: Eighteen months' follow-up data from the randomized, controlled BOOST (Bone marrow transfer to enhance ST-elevation infarct regeneration) trial. Circulation 113:1287-1294; 2006.
76. Mohyeddin-Bonab, M.; Mohamad-Hassani, M. R.; Alimoghaddam, K.; Sanatkar, M.; Gasemi, M.; Mirkhani, H.; Radmehr, H.; Salehi, M.; Eslami, M.; Farhig-Parsa, A.; Emami-Razavi, H.; Alemohammad, M. G.; Solimani, A. A.; Ghavamzadeh, A.; Nikbin, B. Autologous in vitro expanded mesenchymal stem cell therapy for human old myocardial infarction. Arch. Iran. Med. 10:467-473; 2007.
77. Moore, K. A.; Lemischka, I. R. Stem cells and their niches. Science 311:1880-1885; 2006.
78. Moscoso, I.; Centeno, A.; López, E.; Rodriguez-Barbosa, J. I.; Santamarina, I.; Filgueira, P.; Sánchez, M. J.; Domínguez-Perles, R.; Peñuelas-Rivas, G.; Domenech, N. Differentiation "in vitro" of primary and immortalized porcine mesenchymal stem cells into cardiomyocytes for cell transplantation. Transplant. Proc. 37:481-482; 2005.
79. Murry, C. E.; Field, L. J.; Menasché, P. Cell-based cardiac repair reflections at the 10-year point. Circulation 112:3174-3183; 2005.
80. Murry, C. E.; Jennings, R. B.; Reimer, K. A. Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 74:1124-1136; 1986.
81. Nassiri, S. M.; Khaki, Z.; Soleimani, M.; Ahmadi, S. H.; Jahanzad, I.; Rabbani, S.; Sahebjam, M.; Ardalan, F. A.; Fathollahi, M. S. The similar effect of transplantation of marrow-derived mesenchymal stem cells with or without prior differentiation induction in experimental myocardial infarction. J. Biomed. Sci. 14:745-755; 2007.
82. Nygren, J. M.; Jovinge, S.; Breitbach, M.; Säwén, P.; Röll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B. K.; Jacobsen, S. E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med.10:494-501; 2004.
83. Oh, H.; Bradfute, S. B.; Gallardo, T. D.; Nakamura, T.; Gaussin, V.; Mishina, Y.; Pocius, J.; Michael, L. H.; Behringer, R. R.; Garry, D. J.; Entman, M. L.; Schneider, M. D. Cardiac progenitor cells from adult myocardium: Homing, differentiation, and fusion after infarction. Proc. Natl. Acad. Sci. USA 100:12313-12318; 2003.
84. Ohnishi, S.; Yanagawa, B.; Tanaka, K.; Miyahara, Y.; Obata, H.; Kataoka, M.; Kodama, M.; Ishibashi-Ueda, H.; Kangawa, K.; Kitamura, S.; Nagaya, N. Transplantation of mesenchymal stem cells attenuates myocardial injury and dysfunction in a rat model of acute myocarditis. J. Mol. Cell. Cardiol. 42:88-97; 2007.
85. Okada, H.; Suzuki, J.; Futamatsu, H.; Maejima, Y.; Hirao, K.; Isobe, M. Attenuation of autoimmune myocarditis in rats by mesenchymal stem cell transplantation through enhanced expression of hepatocyte growth factor. Int. Heart J. 48:649-661; 2007.
86. Okita, K.; Ichisaka, T.; Yamanaka, S. Generation of germline-competent induced pluripotent stem cells. Nature 448:313-317; 2007.
87. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infracted myocardium. Nature 410:701-705; 2001.
88. Orlic, D.; Kajstura, J.; Chimenti, S.; Limana, F.; Jakoniuk, I.; Quaini, F.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Mobilized bone marrow cells repair the infarcted heart, improving function and survival. Proc. Natl. Acad. Sci. USA 98:10344-10349; 2001.
89. Ortiz, L. A.; Gambelli, F.; McBride, C.; Gaupp, D.; Baddoo, M.; Kaminski, N.; Phinney, D. G. Mesenchymal stem cell engraftment in lung is enhanced in response to bleomycin exposure and ameliorates its fibrotic effects. Proc. Natl. Acad. Sci. USA 100:8407-8411; 2003.
90. Parissis, J.; Filippatos, G.; Adamopoulos, S.; Li, X.; Kremastinos, D. T.; Uhal, B. D. Hematopoietic colony stimulating factors in cardiovascular and pulmonary remodeling: Promoters or inhibitors? Curr. Pharm. Design 12:2689-2699; 2006.
91. Pasha, Z.; Wang, Y.; Sheikh, R.; Zhang, D.; Zhao, T.; Ashraf, M. Preconditioning enhances cell survival and differentiation of stem cells during transplantation in infarcted myocardium. Cardiovasc. Res. 77:134-142; 2008.
92. Pelacho, B.; Nakamura, Y.; Zhang, J.; Ross, J.; Heremans, Y.; Nelson-Holte, M.; Lemke, B.; Hagenbrock, J.; Jiang, Y.; Prosper, F.; Luttun, A.; Verfaillie, C. M. Multipotent adult progenitor cell transplantation increases vascularity and improves left ventricular function after myocardial infarction. J. Tissue Eng. Regen. Med. 1:51-59; 2007.
93. Perin, E. C.; Silva, G. V.; Assad, J. A.; Vela, D.; Buja, L. M.; Sousa, A. L.; Litovsky, S.; Lin, J.; Vaughn, W. K.; Coulter, S.; Fernandes, M. R.; Willerson, J. T. Comparison of intracoronary and transendocardial delivery of allogeneic mesenchymal cells in a canine model of acute myocardial infarction. J. Mol. Cell. Cardiol. 44:486-495; 2008.
94. Pevsner-Fischer, M.; Morad, V.; Cohen-Sfady, M.; Rousso-Noori, L.; Zanin-Zhorov, A. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109:1422-1432; 2007.
95. Pittenger, M.; Mackay, A.; Beck, S.; Jaiswal, R.; Douglas, R.; Mosca, J.; Moorman, M.; Simonetti, D.; Craig, S.; Marshak, D. Multilineage potential of adult human mesenchymal stem cells. Science 284:143-147; 1999.
96. Planat-Bénard, V.; Menard, C.; André, M.; Puceat, M.; Perez, A.; Garcia-Verdugo, J. M.; Pénicaud, L.; Casteilla, L. Spontaneous cardiomyocyte differentiation from adipose tissue stroma cells. Circ. Res. 94:223-229; 2004.
97. Raicevic, G.; Najar, M.; Stamatopoulos, B.; De Bruyn, C.; Meuleman, N.; Bron, D.; Toungouz, M.; Lagneaux, L. The source of human mesenchymal stromal cells influences their TLR profile as well as their functional properties. Cell. Immunol. 270:207-216; 2011.
98. Rangappa, S.; Entwistle, J. W.; Wechsler, A. S.; Kresh, J. Y. Cardiomyocyte-mediated contact programs human mesenchymal stem cells to express cardiogenic phenotype. J. Thorac. Cardiovasc. Surg. 126:124-132; 2003.
99. Rangappa, S.; Fen, C.; Lee, E. H.; Bongso, A.; Sim, E. K. Transformation of adult mesenchymal stem cells isolated from the fatty tissue into cardiomyocytes. Ann. Thorac. Surg. 75:775-779; 2003.
100. Schächinger, V.; Erbs, S.; Elsässer, A.; Haberbosch, W.; Hambrecht, R.; Hölschermann, H.; Yu, J.; Corti, R.; Mathey, D. G.; Hamm, C. W.; Süselbeck, T.; Assmus, B.; Tonn, T.; Dimmeler, S.; Zeiher, A. M. Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction. N. Engl. J. Med. 355:1210-1221; 2006.
101. Schächinger, V.; Erbs, S.; Elsässer, A.; Haberbosch, W.; Hambrecht, R.; Hölschermann, H.; Yu, J.; Corti, R.; Mathey, D. G.; Hamm, C. W.; Süselbeck, T.; Werner, N.; Haase, J.; Neuzner, J.; Germing, A.; Mark, B.; Assmus, B.; Tonn, T.; Dimmeler, S.; Zeiher, A. M.; REPAIR-AMI Investigators. Improved clinical outcome after intracoronary administration of bone marrow-derived progenitor cells in acute myocardial infarction: Final 1-year results of the REPAIR-AMI trial. Eur. Heart J. 27:2775-2783; 2006.
102. Shah, V. K.; Desai, A. J.; Vasvani, J. B.; Desai, M. M.; Shah, B. P.; Lall, T. K.; Mashru, M. R.; Shalia, K. K.; Tanavde, V.; Desai, S. S.; Jankharia, B. J. Bone marrow cells for myocardial repair-A new therapeutic concept. Indian Heart J. 59:482-490; 2007.
103. Shah, V. K.; Shalia, K. K. Stem cell therapy in acute myocardial infarction: A pot of gold or Pandora's box. Stem Cells Int. 2011:536758; 2011.
104. Shake, J. G.; Gruber, P. J.; Baumgartner, W. A.; Senechal, G.; Meyers, J.; Redmond, J. M.; Pittenger, M. F.; Martin, B. J. Mesenchymal stem cell implantation in a swine myocardial infarct model: Engraftment and functional effects. Ann. Thorac. Surg. 73:1919-1925; 2002.
105. Shim, W. S.; Jiang, S.; Wong, P.; Tan, J.; Chua, Y. L.; Tan, Y. S.; Sin, Y. K.; Lim, C. H.; Chua, T.; The, M.; Liu, T. C.; Sim, E. Ex vivo differentiation of human adult bone marrow stem cells into cardiomyocyte-like cells. Biochem. Biophys. Res. Commun. 324:481-488; 2004.
106. Silva, G. V.; Litovsky, S.; Assad, J. A.; Sousa, A. L.; Martin, B. J.; Vela, D.; Coulter, S. C.; Lin, J.; Ober, J.; Vaughn, W. K.; Branco, R. V.; Oliveira, E. M.; He, R.; Geng, Y. J.; Willerson, J. T.; Perin, E. C. Mesenchymal stem cells differentiate into an endothelial phenotype, enhance vascular density, and improve heart function in a canine chronic ischemia model. Circulation 111:150-156; 2005.
107. Strauer, B. E.; Brehm, M.; Zeus, T.; Gattermann, N.; Hernandez, A.; Sorg, R. V.; Kögler, G.; Wernet, P. Myocardial regeneration after intracoronary transplantation of human autologous stem cells following acute myocardial infarction. Dtsch. Med. Wochenschr. 126:932-938; 2001.
108. Strauer, B. E.; Brehm, M.; Zeus, T.; Köstering, M.; Hernandez, A.; Sorg, R. V.; Kögler, G.; Wernet, P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918; 2002.
109. Takahashi, K.; Tanabe, K.; Ohnuki, M.; Narita, M.; Ichisaka, T.; Tomoda, K.; Yamanaka, S. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131:861-872; 2007.
110. Takahashi, K.; Yamanaka, S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell 126:663-676; 2006.
111. + cells and nonselected mononuclear cells in patients with acute STEMI and reduced left ventricular ejection fraction: Results of randomized, multicentre Myocardial Regeneration by Intracoronary Infusion of Selected Population of Stem Cells in Acute Myocardial Infarction (REGENT). Trial. Eur. Heart J. 30:1313-1321; 2009.
112. Thomson, J. A.; Itskovitz-Eldor, J.; Shapiro, S. S.; Waknitz, M. A.; Swiergiel, J. J.; Marshall, V. S.; Jones, J. M. Embryonic stem cell lines derived from human blastocysts. Science 282:1145-1147; 1998.
113. Toma, C.; Pittenger, M. F.; Cahill, K. S.; Byrne, B. J.; Kessler, P. D. Human mesenchymal stem cells differentiate to a cardiomyocyte phenotype in the adult murine heart. Circulation 105:93-98; 2002.
114. Tomita, S.; Li, R. K.; Weisel, R. D.; Mickle, D. A.; Kim, E. J.; Sakai, T.; Jia, Z. Q. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation 100:II247-II256; 1999.
115. Valiunas, V.; Doronin, S.; Valiuniene, L.; Potapova, I.; Zuckerman, J.; Walcott, B.; Robinson, R. B.; Rosen, M. R.; Brink, P. R.; Cohen, I. S. Human mesenchymal stem cells make cardiac connexins and form functional gap junctions. J. Physiol. 555:617-626; 2004.
116. van Amerongen, M. J.; Bou-Gharious, G.; Popa, E.; van Ark, J.; Petersen, A. H.; van Dam, G. M.; van Luyn, M. J.; Harmsen, M. C. Bone marrow-derived myofibroblasts contribute functionally to scar formation after myocardial infarction. J. Pathol. 214:377-386; 2008.
117. van Laake, L. W.; Passier, R.; Monshouwer-Kloots, J.; Verkleij, A. J.; Lips, D. J.; Freund, C.; den Ouden, K.; Ward-van Oostwaard, D.; Korving, J.; Tertoolen, L. G.; van Echteld, C. J.; Doevendans, P. A.; Mummery, C. L. Human embryonic stem cell-derived cardiomyocytes survive and mature in the mouse heart and transiently improve function after myocardial infarction. Stem Cell Res. 1:9-24; 2007.
118. Wagner, W.; Roderburg, C.; Wein, F.; Diehlmann, A.; Frankhauser, M.; Schubert, R.; Eckstein, V.; Ho, A. D. Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors. Stem Cells 25:2638-2647; 2007.
119. Wagner, W.; Wein, F.; Roderburg, C.; Saffrich, R.; Faber, A.; Krause, U.; Schubert, M.; Benes, V.; Eckstein, V.; Maul, H.; Ho, A. D. Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction. Exp. Hematol. 35:314-325; 2007.
120. Wakitani, S.; Saito, T.; Caplan, A. I. Myogenic cells derived from rat bone marrow mesenchymal stem cells exposed to 5-azacytidine. Muscle Nerve 18:1417-1426; 1995.
121. Wang, J. S.; Shum-Tim, D.; Galipeau, J.; Chedrawy, E.; Eliopoulos, N.; Chiu, R. C. Marrow stromal cells for cellular cardiomyoplasty: Feasibility and potential clinical advantages. J. Thorac. Cardiovasc. Surg. 120:999-1005; 2000.
122. - cardiac progenitor cell population in postinfarction left ventricular remodeling. Stem Cell 24:1779-1788; 2006.
123. Wernig, M.; Meissner, A.; Foreman, R.; Brambrink, T.; Ku, M.; Hochedlinger, K.; Bernstein, B. E.; Jaenisch, R. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state. Nature 448:318-324; 2007.
124. Williams, A. R.; Trachtenberg, B.; Velazquez, D. L.; McNiece, I.; Altman, P.; Rouy, D.; Mendizabal, A. M.; Pattany, P. M.; Lopera, G. A.; Fishman, J.; Zambrano, J. P.; Heldman, A. W.; Hare, J. M. Intramyocardial stem cell injection in patients with ischemic cardiomyopathy: Functional recovery and reverse remodeling. Circ. Res. 108:792-796; 2011.
125. Winter, E. M.; Grauss, R. W.; Hogers, B.; van Tuyn, J.; van der Geest, R. Lie-Venema, H.; Steijn, R. V.; Maas, S.; DeRuiter, M. C.; deVries, A. A.; Steendijk, P.; Doevendans, P. A.; van der Laarse, A.; Poelmann, R. E.; Schalij, M. J.; Atsma, D. E.; Gittenberger-de Groot, A. C. Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation 116:917-927; 2007.
126. Wollert, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148; 2004.
127. Xu, M.; Uemura, R.; Dai, Y.; Wang, Y.; Pasha, Z.; Ashraf, M. In vitro and in vivo effects of bone marrow stem cells on cardiac structure and function. J. Mol. Cell. Cardiol. 42:441-448; 2007.
128. Xu, W.; Zhang, X.; Qian, H.; Zhu, W.; Sun, X.; Hu, J.; Zhou, H.; Chen, Y. Mesenchymal stem cells from adult human bone marrow differentiate into a cardiomyocyte phenotype in vitro. Exp. Biol. Med. 229:623-631; 2004.
129. Yeh, E. T. H.; Zhang, S.; Wu, H. D.; Korbling, M.; Willerson, J. T.; Estrov, Z. Transdifferentiation of human peripheral blood CD34-enriched cell population into cardiomyocytes, endothelial cells, and smooth muscle cells in vivo. Circulation 108:2070-2073; 2003.
130. Yoon, J.; Min, B. G.; Kim, Y. H.; Shim, W. J.; Ro, Y. M.; Lim, D. S. Differentiation, engraftment and functional effects of pre-treated mesenchymal stem cells in a rat myocardial infarct model. Acta Cardiol. 60:277-284; 2005.
131. Yoon, Y. S.; Park, J. S.; Tkebuchava, T.; Luedeman, C.; Losordo, D. W. Unexpected severe calcification after transplantation of bone marrow cells in acute myocardial infarction. Circulation 109:3154-3157; 2004.
132. + stem cells in a nonhuman primate model. Stem Cells 23:355-364; 2005.
133. Young, P. P.; Vaughan, D. E.; Hatzopoulos, A. K. Biologic properties of endothelial progenitor cells and their potential for cell therapy. Prog. Cardiovasc. Dis. 49:421-429; 2007.
134. Zeng, L.; Hu, Q.; Wang, X.; Mansoor, A.; Lee, J.; Feygin, J.; Zhang, G.; Suntharalingam, P.; Boozer, S.; Mhashilkar, A.; Panetta, C. J.; Swingen, C.; Deans, R.; From, A. H.; Bache, R. J.; Verfaillie, C. M.; Zhang, J. Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling. Circulation 115:1866-1875; 2007.